NCT00849186View on ClinicalTrials.gov

Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

April 30, 2010

Conditions
Kidney Cancer
Interventions
DRUG

sunitinib malate

oral

PROCEDURE

neoadjuvant therapy

IV

PROCEDURE

therapeutic conventional surgery

Surgery

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00849186 - Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter